
Expert explains why Alzheimer disease remains complex, how biomarkers and imaging track amyloid, and what new anti-tau and anti-inflammatory drugs emerge.

Dr Tcheremissine is a professor and research director in the Department of Psychiatry and Behavioral Medicine at Atrium Health/Wake Forest Medical University-Charlotte Campus.

Expert explains why Alzheimer disease remains complex, how biomarkers and imaging track amyloid, and what new anti-tau and anti-inflammatory drugs emerge.